, Volume 46, Issue 3, pp 189–193 | Cite as

Characterization of necrotic meningioma using diffusion MRI, perfusion MRI, and MR spectroscopy: case report and review of the literature

  • I. HartingEmail author
  • M. Hartmann
  • M. M. Bonsanto
  • C. Sommer
  • K. Sartor
Diagnostic Neuroradiology


Necrotic meningiomas are relatively rare, accounting for 1.3–3.9% of primary intracranial tumours and for 10–15% of meningiomas, but are of special clinical importance as they may resemble metastases or malignant gliomas. We report the magnetic resonance findings of diffusion-weighted imaging, perfusion-weighted imaging, and spectroscopy in a patient with a necrotic meningioma, in whom clinical symptoms and signs suggested a central nervous system infection.


Meningioma Necrotic meningioma Diffusion Perfusion Spectroscopy MR imaging 


  1. 1.
    Kleihues P, Cavenee WK (2000) Pathology and genetics of tumors of the nervous system. IARCGoogle Scholar
  2. 2.
    Buetow MP, Buetow PC, Smirniotopoulos JG (1991) Typical, atypical and misleading features in meningioma. Radiographics 11:1087–1106PubMedGoogle Scholar
  3. 3.
    Odake G (1992) Cystic meningioma: report of three patients. Neurosurgery 30:935–940PubMedGoogle Scholar
  4. 4.
    Ebisu T, Tanaka C, Umeda M, et al (1996) Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 14:1113–1116PubMedGoogle Scholar
  5. 5.
    Hartmann M, Jansen O, Heiland S, et al (2001) Restricted diffusion with ring enhancement is not pathognomonic for brain abscesses. AJNR Am J Neuroradiol 22:1738–1742PubMedGoogle Scholar
  6. 6.
    Grand S, Passaro G, Ziegler A, et al (1999) Necrotic tumor versus brain abscess: importance of amino acids detected at1H MR spectroscopy—initial results. Radiology 213:785–793PubMedGoogle Scholar
  7. 7.
    Poptani H, Gupta RK, Jain VK, et al (1995) Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imaging 13:1019–1029PubMedGoogle Scholar
  8. 8.
    Burtscher IM, Holtas S (1999) In vivo proton MR spectroscopy of untreated and treated brain abscesses. AJNR Am J Neuroradiol 20:1049–1053PubMedGoogle Scholar
  9. 9.
    Hajnal JV, Doran M, Hall AS, et al (1991) MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathological considerations. J Comput Assist Tomogr 15:1–18PubMedGoogle Scholar
  10. 10.
    Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F (1997) MR diffusion imaging of human intracranial tumors. Neuroradiology 39:483–489CrossRefPubMedGoogle Scholar
  11. 11.
    Aronen HJ, Gazit IE, Louis DN, et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMedGoogle Scholar
  12. 12.
    Sugahara T, Korogi Y, Ikushima I, et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479–1486Google Scholar
  13. 13.
    Hartmann M, Harting I, Heiland S, et al (2000) Value of preoperative diffusion- and perfusion-weighted MR imaging in cerebral gliomas. DGNR (abstract)Google Scholar
  14. 14.
    Castillo M, Kwock L(1999) Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Top Magn Reson Imaging 10:104–113PubMedGoogle Scholar
  15. 15.
    Gill SS, Thomas DG, Van Bruggen N, et al (1990) Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 14:497–504PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • I. Harting
    • 1
    Email author
  • M. Hartmann
    • 1
  • M. M. Bonsanto
    • 2
  • C. Sommer
    • 3
    • 4
  • K. Sartor
    • 1
  1. 1.Department of NeuroradiologyUniversity of Heidelberg Medical SchoolHeidelbergGermany
  2. 2.Department of NeurosurgeryUniversity of Heidelberg Medical SchoolHeidelbergGermany
  3. 3.Department of NeuropathologyUniversity of Heidelberg Medical SchoolHeidelbergGermany
  4. 4.Neuropathology, Department of PathologyUniversity of Ulm Medical SchoolUlmGermany

Personalised recommendations